RaySearch Laboratories AB has entered into an exclusive distribution agreement with the Chinese distributor Kang Li Da Trading Corporation, based in Beijing. The agreement means that Kang Li Da will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation® on the entire Chinese market.
China is one of the largest radiation therapy markets globally with approximately 1300 radiation therapy clinics. There is a strong focus on improving healthcare so the radiation therapy sector is growing very rapidly and the number of clinics is expected to increase to 2,000 in less than five years. RayStation® is pending regulatory clearance in China and the approval process is expected to last approximately a year and a half.
Kang Li Da was founded in 1996 and is a leading distributor of radiation therapy equipment in China. The company has approximately 20 employees and represents a wide range of international radiation therapy equipment suppliers serving more than 500 customers. They are highly experienced in the treatment planning field where they have been active form more than a decade.
“China is the fastest growing radiation therapy market so this agreement is extremely important to us. Kang Li Da is a highly experienced distributor of radiation therapy equipment with a broad geographical coverage and excellent track record. We are very excited that they have selected to work exclusively with us within treatment planning and we are looking forward to work closely together to establish RayStation as a leading product on the Chinese market ”, says Johan Löf, CEO of RaySearch.
“We are honored to establish a partnership with RaySearch. We see a great opportunity in bringing RaySearch’s high quality products to the Chinese market. RaySearch has a long track record of developing the best solutions for advanced treatment planning. RayStation® follows that tradition combining unique advanced features with unparalleled ease of use thanks to its modern user interface. We will start demonstrating RayStation® for our customers immediately and I am convinced that it will be very well received by the Chinese radiation therapy community”, says Frank Qian, CEO of Kang Li Da.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for both photon and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian, Accuray and Siemens. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30